Correction: Psychedelics and the Human Receptorome
PLoS ONE March 4, 2010 correction DOI: 10.1371/annotation/e580a864-cf13-40c2-9bd9-b9687a6f0fe4 via OpenAlex
Summary
AI-generated from the abstractPsychedelic drugs, particularly phenylalkylamines, interact with many more receptor types than previously thought. New affinity data for 25 psychedelic drugs at 51 receptors, transporters, and ion channels, plus literature data for 10 additional drugs, show these compounds bind to 42 of 49 broadly assayed sites, not just the 5-HT2A and 5-HT2C receptors. A new normalization method allows direct comparison of multi-receptor profiles across drugs. The 35 drugs display diverse interaction patterns with 18 different receptor classes, which may explain their qualitatively different mental effects. This diversity suggests psychedelics could be used as probes to study how various receptor systems contribute to human consciousness.
Study at a glance
| Characteristics | Reference work with new experimental data and literature review Qualitative |
|---|---|
| Keywords | Receptor Agonism Pharmacology Neuroscience Psychology |
| Citations | 57 |
| Key finding | Psychedelic drugs, especially phenylalkylamines, are not as selective as generally believed, interacting with 42 of 49 broadly assayed sites, and their diverse receptor interaction patterns may underlie qualitative differences in their effects. |
Abstract
We currently understand the mental effects of psychedelics to be caused by agonism or partial agonism of 5-HT 2A (and possibly 5-HT 2C ) receptors, and we understand that psychedelic drugs, especially phenylalkylamines, are fairly selective for these two receptors.This manuscript is a reference work on the receptor affinity pharmacology of psychedelic drugs.New data is presented on the affinity of twenty-five psychedelic drugs at fifty-one receptors, transporters, and ion channels, assayed by the National Institute of Mental Health -Psychoactive Drug Screening Program (NIMH-PDSP).In addition, comparable data gathered from the literature on ten additional drugs is also presented (mostly assayed by the NIMH-PDSP).A new method is introduced for normalizing affinity (K i ) data that factors out potency so that the multi-receptor affinity profiles of different drugs can be directly compared and contrasted.The method is then used to compare the thirty-five drugs in graphical and tabular form.It is shown that psychedelic drugs, especially phenylalkylamines, are not as selective as generally believed, interacting with forty-two of forty-nine broadly assayed sites.The thirty-five drugs of the study have very diverse patterns of interaction with different classes of receptors, emphasizing eighteen different receptors.This diversity of receptor interaction may underlie the qualitative diversity of these drugs.It should be possible to use this diverse set of drugs as probes into the roles played by the various receptor systems in the human mind.